These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 3838691)

  • 1. Cholecystokinin antagonists selectively potentiate analgesia induced by endogenous opiates.
    Watkins LR; Kinscheck IB; Kaufman EF; Miller J; Frenk H; Mayer DJ
    Brain Res; 1985 Feb; 327(1-2):181-90. PubMed ID: 3838691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentiation of opiate analgesia and apparent reversal of morphine tolerance by proglumide.
    Watkins LR; Kinscheck IB; Mayer DJ
    Science; 1984 Apr; 224(4647):395-6. PubMed ID: 6546809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of morphine analgesia by the cholecystokinin antagonist proglumide.
    Watkins LR; Kinscheck IB; Mayer DJ
    Brain Res; 1985 Feb; 327(1-2):169-80. PubMed ID: 3838690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation of systemic morphine analgesia in humans by proglumide, a cholecystokinin antagonist.
    Price DD; von der Gruen A; Miller J; Rafii A; Price C
    Anesth Analg; 1985 Aug; 64(8):801-6. PubMed ID: 4014744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic administration of cholecystokinin antagonists reverses the enhancement of spinal morphine analgesia induced by acute pretreatment.
    Kellstein DE; Mayer DJ
    Brain Res; 1990 May; 516(2):263-70. PubMed ID: 2364292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple endogenous opiate and non-opiate analgesia systems: evidence of their existence and clinical implications.
    Watkins LR; Mayer DJ
    Ann N Y Acad Sci; 1986; 467():273-99. PubMed ID: 3014973
    [No Abstract]   [Full Text] [Related]  

  • 7. The nature of conditioned anti-analgesia: spinal cord opiate and anti-opiate neurochemistry.
    Wiertelak EP; Yang HY; Mooney-Heiberger K; Maier SF; Watkins LR
    Brain Res; 1994 Jan; 634(2):214-26. PubMed ID: 8131071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opiate antagonistic function of cholecystokinin in analgesia and energy balance systems.
    Faris PL
    Ann N Y Acad Sci; 1985; 448():437-47. PubMed ID: 3861127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The opposite effects of the opiate antagonist naloxone and the cholecystokinin antagonist proglumide on placebo analgesia.
    Benedetti F
    Pain; 1996 Mar; 64(3):535-543. PubMed ID: 8783319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cholecystokinin octapeptide (CCK-8) antagonized analgesia mediated by mu and kappa opioid receptors].
    Wang XH; Wang XJ; Han JS
    Sheng Li Xue Bao; 1990 Jun; 42(3):219-25. PubMed ID: 1982023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of beta-endorphin effects by proglumide in rats.
    Katsuura G; Itoh S
    Eur J Pharmacol; 1985 Jan; 107(3):363-6. PubMed ID: 3156751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral evidence for cholecystokinin-opiate interactions in neonatal rats.
    Weller A; Blass EM
    Am J Physiol; 1988 Dec; 255(6 Pt 2):R901-7. PubMed ID: 3202224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphine-induced analgesia in the rat paw pressure test is blocked by CCK and enhanced by the CCK antagonist MK-329.
    O'Neill MF; Dourish CT; Iversen SD
    Neuropharmacology; 1989 Mar; 28(3):243-7. PubMed ID: 2725851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kappa opiate receptors mediate tail-shock induced antinociception at spinal levels.
    Watkins LR; Wiertelak EP; Maier SF
    Brain Res; 1992 Jun; 582(1):1-9. PubMed ID: 1354010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholecystokinin octapeptide antagonized opioid analgesia mediated by mu- and kappa- but not delta-receptors in the spinal cord of the rat.
    Wang XJ; Wang XH; Han JS
    Brain Res; 1990 Jul; 523(1):5-10. PubMed ID: 1976419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholecystokinin and pain: a review.
    McRoberts JW
    Anesth Prog; 1986; 33(2):87-90. PubMed ID: 2872841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of CCK caerulein, and CCK antagonists in nociception.
    Baber NS; Dourish CT; Hill DR
    Pain; 1989 Dec; 39(3):307-328. PubMed ID: 2694075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antianalgesic action of dynorphin A mediated by spinal cholecystokinin.
    Rady JJ; Holmes BB; Fujimoto JM
    Proc Soc Exp Biol Med; 1999 Mar; 220(3):178-83. PubMed ID: 10193446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spinal co-administration of cholecystokinin antagonists with morphine prevents the development of opioid tolerance.
    Kellstein DE; Mayer DJ
    Pain; 1991 Nov; 47(2):221-229. PubMed ID: 1762818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of cholecystokinin in the control of nociception and food intake.
    Faris PL
    Prog Clin Biol Res; 1985; 192():159-66. PubMed ID: 4080709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.